175 related articles for article (PubMed ID: 29200874)
1. Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.
Feng SD; Mao Z; Liu C; Nie YS; Sun B; Guo M; Su C
Onco Targets Ther; 2017; 10():5591-5604. PubMed ID: 29200874
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.
Lou W; Chen Q; Ma L; Liu J; Yang Z; Shen J; Cui Y; Bian XW; Qian C
J Mol Med (Berl); 2013 Jun; 91(6):715-25. PubMed ID: 23292172
[TBL] [Abstract][Full Text] [Related]
3. Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo.
Zuo L; Tao H; Xu H; Li C; Qiao G; Guo M; Cao S; Liu M; Lin X
Drug Des Devel Ther; 2020; 14():3495-3507. PubMed ID: 32921986
[TBL] [Abstract][Full Text] [Related]
4. Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma.
Lei W; Wang S; Yang C; Huang X; Chen Z; He W; Shen J; Liu X; Qian W
Sci Rep; 2016 Aug; 6():32174. PubMed ID: 27552933
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.
Zhao Y; Tu MJ; Yu YF; Wang WP; Chen QX; Qiu JX; Yu AX; Yu AM
Biochem Pharmacol; 2015 Dec; 98(4):602-13. PubMed ID: 26518752
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1252-5p, regulated by Myb, inhibits invasion and epithelial-mesenchymal transition of pancreatic cancer cells by targeting NEDD9.
Xue Y; Wu T; Sheng Y; Zhong Y; Hu B; Bao C
Aging (Albany NY); 2021 Jul; 13(14):18924-18945. PubMed ID: 34314382
[TBL] [Abstract][Full Text] [Related]
7. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
8. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
9. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
10. The Optimal Outcome of Suppressing Ewing Sarcoma Growth
Li DF; Yuan Y; Tu MJ; Hu X; Li YZ; Yi WR; Li PC; Zhao Y; Cheng Z; Yu AM; Jian C; Yu AX
Front Oncol; 2020; 10():222. PubMed ID: 32161722
[TBL] [Abstract][Full Text] [Related]
11. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
Han Y; Meng F; Venter J; Wu N; Wan Y; Standeford H; Francis H; Meininger C; Greene J; Trzeciakowski JP; Ehrlich L; Glaser S; Alpini G
J Hepatol; 2016 Jun; 64(6):1295-304. PubMed ID: 26923637
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
13. miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells.
Jin K; Xiang Y; Tang J; Wu G; Li J; Xiao H; Li C; Chen Y; Zhao J
Tumour Biol; 2014 Feb; 35(2):1503-10. PubMed ID: 24078448
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models.
Raimondi G; Gea-Sorlí S; Otero-Mateo M; Fillat C
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203557
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.
Yu J; Zhao Y; Liu C; Hu B; Zhao M; Ma Y; Jiang J
Clin Transl Oncol; 2020 Jan; 22(1):60-69. PubMed ID: 31093891
[TBL] [Abstract][Full Text] [Related]
16. miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.
Adams BD; Wali VB; Cheng CJ; Inukai S; Booth CJ; Agarwal S; Rimm DL; Győrffy B; Santarpia L; Pusztai L; Saltzman WM; Slack FJ
Cancer Res; 2016 Feb; 76(4):927-39. PubMed ID: 26676753
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.
de Antonellis P; Medaglia C; Cusanelli E; Andolfo I; Liguori L; De Vita G; Carotenuto M; Bello A; Formiggini F; Galeone A; De Rosa G; Virgilio A; Scognamiglio I; Sciro M; Basso G; Schulte JH; Cinalli G; Iolascon A; Zollo M
PLoS One; 2011; 6(9):e24584. PubMed ID: 21931765
[TBL] [Abstract][Full Text] [Related]
18. miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1).
Han Z; Zhang Y; Yang Q; Liu B; Wu J; Zhang Y; Yang C; Jiang Y
Oncotarget; 2015 May; 6(15):13149-63. PubMed ID: 25909221
[TBL] [Abstract][Full Text] [Related]
19. Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion.
Li L; Xie X; Luo J; Liu M; Xi S; Guo J; Kong Y; Wu M; Gao J; Xie Z; Tang J; Wang X; Wei W; Yang M; Hung MC; Xie X
Mol Ther; 2012 Dec; 20(12):2326-34. PubMed ID: 23032974
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2.
Su G; Sun G; Liu H; Shu L; Liang Z
Heart Vessels; 2018 Oct; 33(10):1185-1194. PubMed ID: 29704100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
